Resolvins
Charles Nicholas Serhan, Song Hong, Karsten Gronert, Sean P. Colgan, Pallavi R. Devchand, Gudrun E. Mirick, Rose‐Laure Moussignac
The Journal of Experimental Medicine · 2002 · 1,678 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G. E., & Moussignac, R. (2002). Resolvins. The Journal of Experimental Medicine, 196(8), 1025–1037. https://doi.org/10.1084/jem.20020760
In text: (Serhan et al., 2002)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
Aspirin (ASA) is unique among current therapies because it acetylates cyclooxygenase (COX)-2 enabling the biosynthesis of R-containing precursors of endogenous antiinflammatory mediators. Here, we report that lipidomic analysis of exudates obtained in the resolution phase from mice treated with ASA and docosahexaenoic acid (DHA) (C22:6) produce a novel family of bioactive 17R-hydroxy-containing di- and tri-hydroxy-docosanoids termed resolvins. Murine brain treated with aspirin produced endogenous 17R-hydroxydocosahexaenoic acid as did human microglial cells. Human COX-2 converted DHA to 13-hydroxy-DHA that switched with ASA to 17R-HDHA that also proved a major route in hypoxic endothelial cells. Human neutrophils transformed COX-2-ASA-derived 17R-hydroxy-DHA into two sets of novel di- and trihydroxy products; one initiated via oxygenation at carbon 7 and the other at carbon 4. These compounds inhibited (IC(50) approximately 50 pM) microglial cell cytokine expression and in vivo dermal inflammation and peritonitis at ng doses, reducing 40-80% leukocytic exudates. These results indicate that exudates, vascular, leukocytes and neural cells treated with aspirin convert DHA to novel 17R-hydroxy series of docosanoids that are potent regulators. These biosynthetic pathways utilize omega-3 DHA and EPA during multicellular events in resolution to produce a family of protective compounds, i.e., resolvins, that enhance proresolution status.
Related papers
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor1992
- Adherence to a Mediterranean Diet and Survival in a Greek Population2003
- Dietary pattern analysis: a new direction in nutritional epidemiology2002
- Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease2002
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia2018
Metadata from OpenAlex (CC0). Citations are generated from the published record.